Upgrade to SI Premium - Free Trial

Synergy Pharma (SGYP) Announces Positive Top-Line Results from First Phase 3 Trial of Plecanatide

December 9, 2016 8:31 AM
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced positive top-line results from the first of two pivotal phase 3 clinical trials ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Hot FDA News

Next Articles